Development Team

FDA’s Guidance on Decentralized Trials: A Roadmap for Sites

Event Description: Speakers: Hosted by Scott Stout, CEO, MedVector Rocio Salazar, Associate Director R&D Procurement, Study Procurement Partner Jonathan Helfgott, Johns Hopkins University, President Association of Graduate Regulatory Educators, Former FDA Senior Leader Chris Popple, CEO, Nexus Collaboration Partners Brad Hightower, CEO, Hightower Clinical Research Description How can sites effectively leverage new diversity-focused rules and…

Scott Stout: Decentralizing Clinical Trials and Rewiring Access to Innovation

CRPN Central LIVE! Diversity Inclusion-Have changes occurred? A follow up…

MedVector Founder and CEO On Decentralization in Clinical Research

Craig Lipset, Decentralized Clinical Trial Pioneer and Industry Innovator, Named as MedVector Board Member and Executive Advisor

LOS ANGELES…June 17, 2021 — Craig Lipset, a clinical trials industry innovator and leader, has joined the MedVector team as a new board member and executive advisor. MedVector’s novel Prime-Control Technology platform unlocks access to millions of potential clinical trial participants who are seen every day by physicians who are not seeking to become study…

Scott Stout: Driven to Expand Clinical Trials Beyond Trial Sites

Scott Stout is driven by the desire to compete ─ either racing downhill mountain bikes, riding motorcycles, or growing a business. If there’s someone quicker, smarter or more experienced, so much the better for the agile and entrepreneurial Stout, who loves to compete and win, but doesn’t always have to be “the best.” In fact,…